DE69408244D1 - Vitamin D3-Analoge - Google Patents

Vitamin D3-Analoge

Info

Publication number
DE69408244D1
DE69408244D1 DE69408244T DE69408244T DE69408244D1 DE 69408244 D1 DE69408244 D1 DE 69408244D1 DE 69408244 T DE69408244 T DE 69408244T DE 69408244 T DE69408244 T DE 69408244T DE 69408244 D1 DE69408244 D1 DE 69408244D1
Authority
DE
Germany
Prior art keywords
cholecalciferol
ene
dihydroxy
trihydroxy
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69408244T
Other languages
English (en)
Other versions
DE69408244T2 (de
Inventor
Arthur Mclane John Arthur John
G Reddy Satiyan Satiyanarayama
Radoje Uskokovic Milan R Milan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE69408244D1 publication Critical patent/DE69408244D1/de
Application granted granted Critical
Publication of DE69408244T2 publication Critical patent/DE69408244T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69408244T 1993-10-01 1994-09-17 Vitamin D3-Analoge Expired - Fee Related DE69408244T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/131,264 US5401733A (en) 1993-10-01 1993-10-01 Stable and active metabolites of 1,25-dihydroxy-16-ene-cholecalciferol

Publications (2)

Publication Number Publication Date
DE69408244D1 true DE69408244D1 (de) 1998-03-05
DE69408244T2 DE69408244T2 (de) 1998-08-27

Family

ID=22448675

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69408244T Expired - Fee Related DE69408244T2 (de) 1993-10-01 1994-09-17 Vitamin D3-Analoge

Country Status (15)

Country Link
US (1) US5401733A (de)
EP (1) EP0646576B1 (de)
JP (1) JP2677520B2 (de)
CN (1) CN1041201C (de)
AT (1) ATE162786T1 (de)
AU (1) AU683917B2 (de)
CA (1) CA2133144C (de)
DE (1) DE69408244T2 (de)
DK (1) DK0646576T3 (de)
ES (1) ES2113020T3 (de)
GR (1) GR3026154T3 (de)
NZ (1) NZ264537A (de)
PH (1) PH31439A (de)
RU (1) RU2133738C1 (de)
ZA (1) ZA947453B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9524812D0 (en) * 1995-12-05 1996-02-07 Leo Pharm Prod Ltd Chemical compounds
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
IL130484A (en) * 1996-12-20 2004-07-25 Chugai Pharmaceutical Co Ltd History of -16N-Vitamin-D
DK0884308T3 (da) * 1997-05-02 2003-07-21 Duphar Int Res Fremgangsmåde til at fremstille 16-dehydro vitamin D forbindelser
DE69832699T2 (de) 1997-05-16 2006-08-24 Woman & Infants Hospital Zyklische äther vitamin d3 verbindungen, 1alfa(oh) 3-epi-vitamin d3 verbindungen und deren verwendungen
DE69834109T2 (de) * 1997-05-16 2007-04-19 Woman & Infants Hospital 3-epi-vitamin d2 verbindungen und ihre anwendungen
AU9376998A (en) * 1997-09-02 1999-03-22 Johns Hopkins University School Of Medicine, The Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
JP2004292314A (ja) * 2000-12-14 2004-10-21 Chugai Pharmaceut Co Ltd ケラチノサイト増殖抑制剤

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617297A (en) * 1982-02-12 1986-10-14 Hoffmann-La Roche Inc. Method of treating disease states by the administration of 1α,25,26-trihydroxycholecalciferol
US4594432A (en) * 1983-01-28 1986-06-10 Hoffman-La Roche Inc. Process for the synthesis of 1α,23(S),25-trihydroxycholecalciferol and 1α,23(R),25-trihydroxycholecalciferol
US4501738A (en) * 1983-06-30 1985-02-26 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient to treat pain, pyrexia or inflammatory diseases
US4495181A (en) * 1983-10-03 1985-01-22 The Regents Of The University Of California 1,25-Dihydroxy-24-oxo-vitamin D3 and 1,23,25-trihydroxy-24-oxo-vitamin D3
US4719205A (en) * 1984-01-30 1988-01-12 Wisconsin Alumini Research Foundation Side-chain unsaturated 1-hydroxyvitamin D compounds
JPS6144860A (ja) * 1984-08-10 1986-03-04 Taisho Pharmaceut Co Ltd １α．２５−ジヒドロキシ−２６．２７−ジメチルビタミンＤ↓３
JPS61129130A (ja) * 1984-11-27 1986-06-17 Kureha Chem Ind Co Ltd 抗尿毒症剤
US4612308A (en) * 1984-11-29 1986-09-16 Hoffmann-La Roche Inc. 25,26-Dehydro-1α,23(S,R)-dihydroxycholecalciferol and its epimers
JPS6253960A (ja) * 1985-05-30 1987-03-09 Taisho Pharmaceut Co Ltd ビタミンｄ↓３の誘導体
EP0245524B1 (de) * 1985-11-21 1991-04-17 Taisho Pharmaceutical Co. Ltd Vitamin d3-abkömmling
JPS6391323A (ja) * 1986-10-03 1988-04-22 Kureha Chem Ind Co Ltd 抗尿路結石症剤
US5001118A (en) * 1986-12-29 1991-03-19 Kureha Kagaku Kogyo Kabushiki Kaisha Method for preventing senescence and increasing bone mass
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4851401A (en) * 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
DE4011682A1 (de) * 1990-04-06 1991-10-10 Schering Ag 24-oxa-derivate in der vitamin d-reihe
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives

Also Published As

Publication number Publication date
ZA947453B (en) 1995-04-03
DK0646576T3 (da) 1998-09-23
PH31439A (en) 1998-11-03
DE69408244T2 (de) 1998-08-27
NZ264537A (en) 1996-05-28
JP2677520B2 (ja) 1997-11-17
RU2133738C1 (ru) 1999-07-27
EP0646576B1 (de) 1998-01-28
ATE162786T1 (de) 1998-02-15
CA2133144A1 (en) 1995-04-02
CN1106384A (zh) 1995-08-09
ES2113020T3 (es) 1998-04-16
AU7422594A (en) 1995-04-13
CN1041201C (zh) 1998-12-16
AU683917B2 (en) 1997-11-27
US5401733A (en) 1995-03-28
JPH07179418A (ja) 1995-07-18
CA2133144C (en) 2005-05-24
EP0646576A1 (de) 1995-04-05
RU94035663A (ru) 1996-07-20
GR3026154T3 (en) 1998-05-29

Similar Documents

Publication Publication Date Title
ES2062334T3 (es) Compuestos de 19-nor-vitamina d.
ATE415164T1 (de) (20s)-1alpha-hydroxy-2alpha-methyl und 2beta- methyl-19-nor vitamin d3 und ihre verwendung
ATE247666T1 (de) Wasserlöslische prodrugs von 2,6- diisopropylphenol-analoga
ATE25525T1 (de) N-glycosylierte carbonsaeureamid-derivate, verfahren zu ihrer herstellung sowie ihre verwendung zur beeinflussung der koerpereigenen abwehr.
CY1108686T1 (el) (20s)-1 α-υδροξυ-2-μεθυλενιο-19-νορ-δις-ομοπρεγνακαλσιφερολη και οι χρησεις της
DK0646576T3 (da) Vitamin D3-analoger
ATE537834T1 (de) 2-methylen-19-nor-vitamin d2-verbindungen
DE60018554D1 (de) Arzneimittel zur förderung der neuronalen zelldifferenzierung, die cyclische glycerophosphate und deren analoga enthalten
BG101126A (en) The use of muramylpeptide compounds
ATE528279T1 (de) 3-butenyl-1-aminederivate und ihre verwendung als ih modulatoren von therapie für psychiatrische erkrankungen
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
HU9700118D0 (en) Dinucleoside-5',5'-pyrophosphates
IL70128A (en) 3,7-dimethyl-9-(3-alkyl-4-trifluoromethoxy-phenyl)-nona-2,4,6,8-tetraenoic acid derivatives,their manufacture and pharmaceutical compositions containing them
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
DE69933581D1 (de) Verwendung von humanem wachstumshormon zur vermehrung der anzahl zirkulierender cd34+ zellen, zur wiederherstellung des hämapoietischen- und des immunsystems nach myeloablativer oder antiblastischer therapie, bei transplantation oder re-infusion
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
ATE6057T1 (de) Das pflanzenwachstum regulierende zusammensetzungen, die als aktive substanz derivate von 2-methylen-succinamidsaeure enthalten, und derivate dieser saeure, die in diesen zusammensetzungen verwendbar sind.
EP0551844A3 (de)
GR3020411T3 (en) Novel ascorbic acid derivatives
MX9307679A (es) Derivados de furanona utiles en terapia.
IT1244459B (it) Composizione terapeutica per il trattamento di malattie della pelle quali vitiligine,acne,psoriasi,alopecia,ipotricosi
MX9305151A (es) Metodo para el tratamiento de enfermedades de la piel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee